CollimateHealth
1 known investors
CollimateHealth develops a clinically scalable microbeam radiation technology for cancer treatment, delivering arrays of narrow, micrometer-scale radiation beams at higher doses than conventional broad-beam radiation oncology. The technology aims to trigger immune responses against cancer cells and improve delivery of chemotherapy and immunotherapy into tumor tissue.
Founders & leadership
SB
Stefan BartzschCo-founder & Chief Scientific Officer
JW
Johanna WinterCo-founder & Chief Technology Officer
HM
Hans Maria HeÿnCo-founder & Chief Executive Officer